Navigation Links
Help Your Favorite Charity Win $1,000 from Cold-EEZE®!

DOYLESTOWN, Pa., Sept. 1, 2011 /PRNewswire/ -- ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE®, announced today that they will be donating $1,000 to a well-deserving, locally nominated and voted upon charity every month for 18 months through their "Share Your Cause, Not Your Cold" contest, hosted exclusively on Facebook. The winning charity must be a registered, qualified and valid non-for-profit organization organized under the I.R.S. code 501(c)(3) and be located within the fifty (50) United States and the District of Columbia.

The contest will run from Thursday, September 1, 2011 at 9AM EDT through Sunday, April 1, 2012 at 11:59PM EDT. To nominate a local cause, all one must do is submit a "Cold-EEZE® Share Your Cause, Not Your Cold" Contest Nomination application at Once the nominations for that month have been gathered, a panel of judges selected by Cold-EEZE will select up to five finalists, to be voted on by fans across the nation. The fans will have approximately two weeks to vote and a winner will be announced at the end of every month. Each month a new cause will win $1,000 from Cold-EEZE®!

The winning organization will receive $1,000 and the person who nominated the cause will receive a Flip Camera to film their cause in action to help further awareness for the cause by obtaining footage that will be promoted on the Cold-EEZE® Website, and on the Cold-EEZE® Facebook Fan page, Each person is allowed one submission per month and is encouraged to spread the word to their social network and to encourage them to vote for their cause at!

"At Cold-EEZE®, we've always felt strongly about being involved in the community," says Ted Karkus, Chairman and CEO of ProPhase Labs. "Being involved in charitable work is just another way for Cold-EEZE® to help people feel better. We look forward to hearing all about the local causes that you care most about in your neighborhoods, contributing to them and sharing them with our entire community."

For the official rules and timeline for the "Share Your Cause, Not Your Cold" contest, please visit

About ProPhase Labs

ProPhase Labs (NASDAQ: PRPH) is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® cold remedy family of lozenges clinically

proven to significantly reduce the severity and duration of the common cold. Cold-EEZE® customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities.  ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion").  Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds.  Phusion will formulate and test products to exploit market opportunities within ProPhase's robust over-the-counter distribution channels.   For more information visit us at

Media Contact:  
Ilisa Wirgin/Jenny Miranda

SOURCE ProPhase Labs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
2. Amputees to Show Off Stand-Up Basketball Skills at Long Island, NY Charity Basketball Game
3. Orange County-Based Charity Teams Up With SunPower Corp. to Distribute Wheelchairs in the Philippines
4. Healthcare Scoring System Allows Hospitals To Increase Charity Care
5. OC-Based Charity Teams with International Relief Organization in Holiday Fundraising Drive
6. Hooters of Orange Park to Host Charity Car Wash Raising Money for Breast Cancer Research
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
Breaking Medicine News(10 mins):